Skip to main content

Table 1 Correlations between FLVCR1-AS1 expression and clinical characteristics in PC patients

From: Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway

Clinicopathologic parameters

Case (n = 77)

FLVCR1-AS1 expression

P value

Low

High

 

Total

77

46

31

 

Gender

   

0.611

 Male

42

24

18

 

 Female

35

22

13

 

Age

   

0.89

 ≥ 60

39

23

16

 

 < 60

38

23

15

 

Pathological stage

   

0.001*

 I

23

9

14

 

 II

29

15

14

 

 III-IV

25

22

3

 

T stage

   

0.329

 T1-2

35

23

12

 

 T3-4

42

23

19

 

Lymph node metastasis

   

0.007*

 N0

31

20

11

 

 N1

34

15

19

 

 N2

12

11

1

 

Distant metastasis

   

0.061

 M0

70

39

31

 

 M1

7

7

0

Â